Is oxidative stress a therapeutic target in schizophrenia?
What the nose knows in patients with schizophrenia.
What does the evidence tell us about digital sensors for treatment adherence in patients with schizophrenia and other psychiatric disorders?
How to decrease recidivism for individuals with serious mental illnesses who are released from jails or prisons or discharged from hospitals? Here are several effective mechanisms.
Tardive syndromes include a broad spectrum of abnormal movements. Which movement disorders can resemble tardive dyskinesia? Find out in the quiz.
New evidence links vitamin D status with cognition in patients with psychosis.
Which genes have recently been associated with TD? That question and more in this quiz.
New evidence bolsters the reputation of clozapine as the “gold-standard” antipsychotic for patients with treatment-resistant schizophrenia.
Tips for having a balanced and comprehensive risk-to-benefit discussion with competent patients who want to stop their medications.
Is an effective, well-tolerated treatment for the negative symptoms of schizophrenia on the horizon?